Annexin A9,膜粘连蛋白9抗体

产品编号HZ-5916R
英文名称Annexin A9
中文名称膜粘连蛋白9抗体
别 名annexin 31; annexin A9; annexin XXXI; ANX31; ANXA9; ANXA 9; ANXA-9; pemphaxin; ANXA9_HUMAN .
规格价格0.1ml 0.2ml 
说 明 书0.1ml 0.2ml
研究领域细胞生物 免疫学 细胞粘附分子
抗体来源Rabbit
克隆类型Polyclonal
Annexin A9,膜粘连蛋白9抗体交叉反应Human, Mouse, Rat, Dog, Pig, Cow, Horse,
产品应用WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量38kDa
性 状Lyophilized or Liquid
浓 度1mg/1ml
免 疫 原KLH conjugated synthetic peptide derived from human Annexin A9
亚 型IgG
纯化方法affinity purified by Protein A
储 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存条件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Annexin A9,膜粘连蛋白9抗体PubMedPubMed
产品介绍background:
ANXA9 may act as a low affinity receptor for acetylcholine and is expressed in the stratified squamous skin epithelium, but not in epithelia of other types (at protein level). ANXA9 is one of the target molecules recognized by autoantibodies in patients with pemphigus vulgaris, a rare, autoimmune skin disease in which epidermal blisters occur as the result of the loss of cell-cell adhesion.

Function:
Low affinity receptor for acetylcholine known to be targeted by disease-causing pemphigus vulgaris antibodies in keratinocytes.

Subunit:
Homodimer.

Tissue Specificity:
Expressed in the stratified squamous skin epithelium, but not in epithelia of other types (at protein level).

Similarity:
Belongs to the annexin family.
Contains 4 annexin repeats.

Database links:
UniProtKB/Swiss-Prot: O76027.3

Annexin A9,膜粘连蛋白9抗体Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.